FindTrial
Sign In

Sequelae of SAR-CoV2 infection on Quality of Life and Lung

Sequelae of SAR-CoV2 infection on Quality of Life and Lung

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20201006001
Enrollment
100
Registered
2020-10-06
Start date
2020-06-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post SAR&#45

Interventions

Subjects who had previous history of SAR&#45
CoV2 infection&#44
with or without respiratory symptom.
Health Services Research
CoV2 infection

Sponsors

Ratchadapisek Sompoch Funding, Faculty of Medicine, Chulalongkorn University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. All subjects who had history of SAR-CoV2 infection 2. Age > 18 years 3. Be able to perform pulmonary function test

Exclusion criteria

Exclusion criteria: 1. Has contraindication to perform pulmonary function test 2. Has active respiraotry infection 3. Terminal illness 4. No be able to follow up

Design outcomes

Primary

MeasureTime frame
Pulmonary functions (FEV1, FVC, DLCO) 12 months after admission Pulmonary function tests (FEV1, FVC, DLCO),Pulmonary functions (FEV1, FVC, DLCO) 3 months after admission Pulmonary function tests—

Secondary

MeasureTime frame
Qulatity of life 3 months after admission SGRQ, EQ5D,Functional capacity 3 months after admission 6MWT (m), SPPB,Qulatity of life 6,9,12 months after admission SGRQ, EQ5D,Functional capacity 6,9,12 months after admission 6MWT (m), SPPB—

Countries

Thailand

Contacts

Public ContactWorawan Sirichana

Faculty of Medicine, Chulalongkorn University

wsirichana@gmail.com6622564000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026